Literature DB >> 2139364

Action of pertussigen (pertussis toxin) on serum IgE and on Fc epsilon receptors on lymphocytes.

J J Munoz1, M G Peacock.   

Abstract

Pertussigen (pertussis toxin (PT] is one of the most effective stimulators of IgE production in mice and rats. Employing flow microfluorimetric analysis (FMF), we showed that PT increases the percentage of blood and spleen lymphocytes with IgE on their surface. The percentage of IgE-bearing cells in the spleen of normal untreated C57Bl/10SCN mice of various ages varied from 2.2 to 12.2%, with an average value of 6.1 +/- 5.4%. In mice treated with 400 ng of PT and 1 mg of chicken egg albumin (EA), the percentage of these cells increased, 14 days after immunization, to an average value of 31.1 +/- 2.2%. Immunization of mice with PT alone increase the percentage of IgE-bearing cells only slightly (13.1 +/- 2.2% of the splenic lymphocytes) while injection of 1 mg of EA alone did not have any detectable action. As little as 6 ng of PT, when given simultaneously with 1 mg of EA, increased the percentage of IgE-bearing lymphocytes. A booster dose of 10 micrograms of EA given on Day 14 induced a further increase in the percentage of these cells even when as little as 0.039 ng of PT had been given at the time of initial immunization. PT was effective when given 4 days before or 5 days after EA. EA was effective when given 4 days before or 4 days after PT, but not 8 days after. The increase in IgE-bearing cells was mainly due to cytophilic binding of IgE to receptors for the epsilon chain of IgE (Fc epsilon) on the surface of lymphocytes rather than to a greater number of IgE-producing cells. This was shown by removing the IgE from Fc epsilon receptors by acid treatment which reduced the percentage of IgE-bearing cells to nearly normal values. The antibodies of IgE class with specificity to EA were increased dramatically, while antibodies with specificity to PT were not detected.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139364     DOI: 10.1016/0008-8749(90)90136-f

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  15 in total

1.  Pertussis vaccination and wheezing illnesses in young children: prospective cohort study. The Longitudinal Study of Pregnancy and Childhood Team.

Authors:  J Henderson; K North; M Griffiths; I Harvey; J Golding
Journal:  BMJ       Date:  1999-05-01

2.  Cellular immune activation in Gulf War veterans.

Authors:  Anna Skowera; Matthew Hotopf; Elzbieta Sawicka; Ruben Varela-Calvino; Catherine Unwin; Vasilis Nikolaou; Lisa Hull; Khalida Ismail; Anthony S David; Simon C Wessely; Mark Peakman
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.317

3.  Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.

Authors:  I Marsili; M Pizza; F Giovannoni; G Volpini; M Bartalini; R Olivieri; R Rappuoli; L Nencioni
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

4.  Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood.

Authors:  H R Anderson; J D Poloniecki; D P Strachan; R Beasley; B Björkstén; M I Asher
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

5.  Co-stimulation of T cells via CD28 inhibits human IgE production; reversal by pertussis toxin.

Authors:  C T Van der Pouw-Kraan; H J Rensink; R Rappuoli; L A Aarden
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

6.  Early childhood infection and atopic disorder.

Authors:  I S Farooqi; J M Hopkin
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

7.  Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis.

Authors:  S Peppoloni; L Nencioni; A Di Tommaso; A Tagliabue; P Parronchi; S Romagnani; R Rappuoli; M T De Magistris
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

8.  Antinuclear autoantibodies (ANA) in Gulf War-related illness and chronic fatigue syndrome (CFS) patients.

Authors:  A Skowera; E Stewart; E T Davis; A J Cleare; C Unwin; L Hull; K Ismail; G Hossain; S C Wessely; M Peakman
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

9.  Histamine release from basophils in childhood: age dependency and inhibition by pertussis infection and pertussis toxin.

Authors:  M Griese; G Merkel; R Feldmann; I Bergfeld; D Reinhardt
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

10.  Does pertussis infection induce manifestation of allergy?

Authors:  A Schuster; A Hofmann; D Reinhardt
Journal:  Clin Investig       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.